|
Posted: 3:23 PM Aug 11, 2010
FDA panel favors Glaxo epilepsy drug
Federal health advisers say GlaxoSmithKline's epilepsy drug Potiga appears effective in controlling seizures.
|
|
0 Comments 
WASHINGTON (AP) -- Federal health advisers say GlaxoSmithKline's epilepsy drug Potiga appears effective in controlling seizures.
An agency spokeswoman said the Food and Drug Administration's panel of neurologists voted unanimously that company studies showed the effectiveness of the drug. The panelists noted side effects, including the inability to urinate, but said they could be controlled by carefully monitoring patients.
British drugmaker GlaxoSmithKline PLC has asked the FDA to approve the pill for epilepsy patients who continue experiencing seizures while taking other medications.
Epilepsy drugs already on the market include Johnson & Johnson's Topamax and Pfizer Inc.'s Neurontin.
(Copyright 2010 by The Associated Press. All Rights Reserved.)
- Pot-based prescription drug looks for FDA OK
4 Comments - Tenn. striving to curb pain pill epidemic
3 Comments - TennCare pain pill prescriptions up 48 percent
2 Comments - Axelrod defends administration birth control rule
2 Comments
| Powered: Local.com |
| Popular Searches |
- .DJI
- 12801.23
- -89.23
- -0.69%
- .INX
- 1342.64
- -9.31
- -0.69%
- .IXIC
- 2903.88
- -23.35
- -0.80%
- NYA
- 7992.03
- -89.22
- -1.10%
Quotes updated every 15 minutes
